ATE418995T1 - Formulierungen zur behandlung von männlicher und weiblicher impotenz - Google Patents

Formulierungen zur behandlung von männlicher und weiblicher impotenz

Info

Publication number
ATE418995T1
ATE418995T1 AT05025315T AT05025315T ATE418995T1 AT E418995 T1 ATE418995 T1 AT E418995T1 AT 05025315 T AT05025315 T AT 05025315T AT 05025315 T AT05025315 T AT 05025315T AT E418995 T1 ATE418995 T1 AT E418995T1
Authority
AT
Austria
Prior art keywords
female
impotency
formulations
treating male
male
Prior art date
Application number
AT05025315T
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Antonella Riva
Roberto Seghizzi
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11449866&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE418995(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of ATE418995T1 publication Critical patent/ATE418995T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AT05025315T 2002-05-10 2003-04-30 Formulierungen zur behandlung von männlicher und weiblicher impotenz ATE418995T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000990A ITMI20020990A1 (it) 2002-05-10 2002-05-10 Formulazioni utili nel trattamento dell'impotenza maschile e femminile

Publications (1)

Publication Number Publication Date
ATE418995T1 true ATE418995T1 (de) 2009-01-15

Family

ID=11449866

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05025315T ATE418995T1 (de) 2002-05-10 2003-04-30 Formulierungen zur behandlung von männlicher und weiblicher impotenz
AT03729955T ATE319466T1 (de) 2002-05-10 2003-04-30 Zusammensetzungen zur behandlung der männlichen und weiblichen impotenz

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03729955T ATE319466T1 (de) 2002-05-10 2003-04-30 Zusammensetzungen zur behandlung der männlichen und weiblichen impotenz

Country Status (18)

Country Link
US (1) US7128932B2 (de)
EP (2) EP1503775B1 (de)
JP (1) JP4603351B2 (de)
KR (1) KR20040102212A (de)
CN (2) CN101164559A (de)
AT (2) ATE418995T1 (de)
AU (1) AU2003240478B8 (de)
CA (1) CA2485264A1 (de)
DE (2) DE60303925T2 (de)
DK (2) DK1658854T3 (de)
ES (2) ES2318406T3 (de)
IL (2) IL165081A (de)
IT (1) ITMI20020990A1 (de)
NO (2) NO332805B1 (de)
PT (2) PT1658854E (de)
RU (2) RU2313357C2 (de)
SI (2) SI1658854T1 (de)
WO (1) WO2003094943A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6952691B2 (en) * 2002-02-01 2005-10-04 International Business Machines Corporation Method and system for searching a multi-lingual database
EP1689373B1 (de) * 2003-10-10 2019-04-03 Ethypharm Mikrogranulat mit verzögerter freisetzung mit ginkgo biloba extrakt und herstellungsverfahren dafür
WO2006021930A2 (en) * 2004-08-25 2006-03-02 Femi-X A/S Aphrodisiac herbal composition for a female comprising epimedium grandiflorum, turnera diffusa var. aphrodisiaca, ilex paraguariensis and smilax spp
KR100660116B1 (ko) * 2005-01-26 2006-12-20 (주)포메디 홍삼 및 대두를 주성분으로 포함하는 복합 한방 제제를유효성분으로 함유하는 성기능 개선용 조성물
WO2006111830A2 (en) * 2005-04-20 2006-10-26 Council Of Scientific And Industrial Research Functional aphrodisiac rolled herbal bidis and cigarettes
EP1932531A1 (de) * 2006-12-11 2008-06-18 Finzelberg GmbH & Co. KG Spezialextrakt und seine Verwendung zur Hemmung des Abbaus von cyclischem Guanosinmonophosphat (cGMP)
US8362088B2 (en) * 2006-12-14 2013-01-29 Warnock W Matthew Method and article of manufacture for encapsulating a homeopathic ingredient with a second ingredient
US9918489B2 (en) * 2008-12-17 2018-03-20 Mark Gorris Food-based supplement delivery system
US20100178413A1 (en) * 2008-12-17 2010-07-15 Mark Gorris Food-based Supplement Delivery System
DK2477633T3 (da) * 2009-09-17 2013-09-30 Tradapharma Sagl Kosttilskud til stimulering af den mandlige seksualfunktion
ES2386859B1 (es) * 2011-02-07 2013-03-22 Eduardo Antonio Gómez De Diego Composición natural para aumentar el vigor.
RU2458537C1 (ru) * 2011-03-14 2012-08-20 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики эректильной дисфункции у мужчин
ITLI20110007A1 (it) * 2011-09-10 2013-03-11 Lloyds Internat Credit Llc Una innovativa composizione naturale efficace per la cura dell'impotenza
TW201420745A (zh) * 2012-11-26 2014-06-01 Tian-De Li 擴充男性海綿體的複方精油
US10226418B2 (en) 2014-05-12 2019-03-12 Susie Q, Ltd. Arginine-containing topical composition
US10016477B1 (en) 2015-01-13 2018-07-10 Roger Yomba Ngue Natural composition
IT201700115753A1 (it) * 2017-10-13 2019-04-13 Cristalfarma S R L Integratore per attenuare i disturbi nella donna causati dall’invecchiamento
EP3560488A1 (de) * 2018-04-24 2019-10-30 Procare Health Iberia, S.L. Zusammensetzung zur behandlung weiblicher sexueller dysfunktion
WO2022027122A1 (en) * 2020-08-06 2022-02-10 Ramade & Cia Holding Corp. Compositions with cannabinoids of cannabis sativa for treating erectile and sexual dysfunction
IT202100031175A1 (it) * 2021-12-13 2023-06-13 Anvest Group S R L Composizione per il trattamento della disfunzione erettile
GR1010519B (el) * 2022-07-04 2023-08-10 Νικολαος Τυμπανιδης Καταπινομενο σκευασμα για τονωση της ζωτικοτητας, της αντοχης και της γενικοτερης ευεξιας των ανδρων

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1084746A (zh) * 1992-11-25 1994-04-06 王立本 防治性病的特效壮阳药液及其制作方法
KR0148511B1 (ko) * 1993-09-14 1998-11-02 최형기 성신경과민증 예방 및 치료용 의약조성물
IT1269634B (it) * 1994-05-06 1997-04-08 Indena Spa Medicamento topico ad attivita' cicatrizzante
CN1141185A (zh) * 1996-02-16 1997-01-29 范凯 保健药酒
FR2765483B1 (fr) * 1997-07-04 2000-02-04 Philippe Gorny Medicament destine a traiter les dysfonctions erectiles
RU2125462C1 (ru) * 1998-01-21 1999-01-27 Акционерное общество открытого типа "Фармацевтическая фабрика Санкт- Петербурга" Настойка avena sativa z., молочной спелости, средства на основе avena sativa z. молочной спелости и способ их получения
US6007824A (en) * 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
CA2339356C (en) * 1998-08-03 2007-06-26 Ronald E. Wheeler Prostate formula
JP2003500452A (ja) * 1999-05-27 2003-01-07 アーマディーロ・ファーマシューティカルス・インコーポレーテッド 天然資源から抽出した生物活性物質の医薬製剤
RU2153347C1 (ru) 1999-06-04 2000-07-27 Общество с ограниченной ответственностью "Доктор Н" Гомеопатическое лекарственное средство для лечения импотенции
US6803060B2 (en) * 2000-09-07 2004-10-12 Joe Reyes Composition to boost libido
DE60217679T2 (de) * 2001-07-23 2007-10-25 Alcon Inc. Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
US6444237B1 (en) * 2001-09-13 2002-09-03 Pamela A. Heleen Herbal composition for enhancing sexual response
US20030068391A1 (en) * 2001-10-04 2003-04-10 Harris Dennis H. Ingestible nerve and circulatory nutritional formulation
CN1311019C (zh) * 2002-12-18 2007-04-18 西巴特殊化学品控股有限公司 制备基于三聚氰胺的阻燃剂的方法和聚合物组合物

Also Published As

Publication number Publication date
DK1658854T3 (da) 2009-03-09
ITMI20020990A1 (it) 2003-11-10
CN1652806A (zh) 2005-08-10
NO332805B1 (no) 2013-01-14
IL165081A (en) 2009-09-22
DE60303925D1 (de) 2006-05-04
PL371674A1 (pl) 2005-06-27
AU2003240478B8 (en) 2009-08-06
WO2003094943A1 (en) 2003-11-20
EP1658854A2 (de) 2006-05-24
RU2440127C2 (ru) 2012-01-20
EP1658854B1 (de) 2008-12-31
EP1503775A1 (de) 2005-02-09
DE60325657D1 (de) 2009-02-12
ES2318406T3 (es) 2009-05-01
PT1503775E (pt) 2006-07-31
JP2005529915A (ja) 2005-10-06
SI1658854T1 (sl) 2009-04-30
NO20120620L (no) 2004-11-08
IL192138A0 (en) 2008-12-29
KR20040102212A (ko) 2004-12-03
EP1658854A3 (de) 2007-04-25
NO20044855L (no) 2004-11-08
ITMI20020990A0 (it) 2002-05-10
AU2003240478A1 (en) 2003-11-11
EP1503775B1 (de) 2006-03-08
SI1503775T1 (sl) 2006-06-30
CN100356935C (zh) 2007-12-26
HK1085374A1 (zh) 2006-08-25
RU2007108559A (ru) 2008-09-20
JP4603351B2 (ja) 2010-12-22
RU2313357C2 (ru) 2007-12-27
ATE319466T1 (de) 2006-03-15
PT1658854E (pt) 2009-03-23
CN101164559A (zh) 2008-04-23
IL165081A0 (en) 2005-12-18
AU2003240478B2 (en) 2007-05-31
DK1503775T3 (da) 2006-07-17
US7128932B2 (en) 2006-10-31
ES2259139T3 (es) 2006-09-16
US20050220905A1 (en) 2005-10-06
IL192138A (en) 2010-12-30
CA2485264A1 (en) 2003-11-20
RU2004132833A (ru) 2005-06-27
DE60303925T2 (de) 2006-08-24

Similar Documents

Publication Publication Date Title
IL192138A0 (en) Formulations useful in the treatment of male and female impotence
ATE319467T1 (de) Formulierungen zur behandlung von männlicher und weiblicher impotenz
ATE489956T1 (de) Formulierungen enthaltend salicylate und deren verwendung zur behandlung von entzündlicher darmerkrankung
DE602004016729D1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
NO20062355L (no) Sammensetninger for behandling av sykdom i munnhulen og ovre andedrettssystem
PT1425005E (pt) Composicao farmaceutica que compreende lumiracoxib
EA200800880A1 (ru) Комбинация росиглитазона и донепезила, предназначенная для улучшения когнитивной функции
ATE407690T1 (de) Topische pharmazeutische zusammensetzungen enthaltend aktive natürliche bestandteile zur verhütung und behandlung von mucosalen entzündungprozessen
ATE215817T1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
TW200505429A (en) Pharmaceutical composition
DE602005021115D1 (de) Verfahren und zusammensetzungen zur oralen fts-abgabe
DE60108227D1 (de) Verwendung von morinda citrifolia zur behandlung von tinnitus
NO20061223L (no) Orale sammensetninger for behandlingen av cellulitt
DE60126504D1 (de) Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa
ATE493976T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose
ATE372771T1 (de) Verwendung von 1-thiadibenzo e,h azulenen zur herstellung von pharmazeutischen formulierungen für die behandlung und prävention von erkrankungen und störungen des zentralen nervensystems
ATE411014T1 (de) Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblichem brustkrebs
UA39044A (uk) Склад для лікування хвороб пародонта
EA200801499A1 (ru) Способ минерализации тканей корня зуба

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1658854

Country of ref document: EP